Day: March 19, 2024

DURHAM, N.C., March 19, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), today announced that it has been awarded a contract in excess of $1 million with an NIH-funded researcher at a major university. The program involves process optimization and development of a therapeutic antibody, which Scorpius will manufacture for preclinical studies. The work will be conducted in the Company’s state-of-the-art process development lab and cGMP cleanrooms in its Mammalian Building, which is ideally suited for early-stage programs using CHO cell lines. Following process optimization and development, the Company expects to expand the scope of the agreement to include Phase 1 clinical manufacturing. Jeff Wolf, CEO of Scorpius, stated, “Scorpius...

Project includes the development of a unique, ADA-compliant manufacturing facility, employing wounded vets to produce the housing unitsADA-compliant manufacturing facility to be built in McClean, OklahomaADA-compliant manufacturing facility to be built in McClean, OklahomaADA-compliant manufacturing facility to be built in McClean, Oklahoma MIAMI, FL, March 19, 2024 (GLOBE NEWSWIRE) — Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures, and Soldier On, Inc., a private nonprofit organization committed to ending veteran homelessness, announced today entry into a non-binding Letter of Intent (LOI) to design, build and operate an 800-unit supportive housing community for veterans, first responders and others...

CHICAGO, March 19, 2024 (GLOBE NEWSWIRE) — SP+® Corporation (SP+), (Nasdaq: SP) a best-in-class technology and operations management provider of mobility services for aviation, commercial, hospitality, and institutional clients throughout North America and Europe, announces complimentary Bags® Remote Airline Check-in and Bag Drop services at Harry Reid International Airport (LAS) in Las Vegas, Nevada. Customers using the Bags Check-in and Bag Drop experience may now check-in for their flight on multiple airlines, obtain airline boarding passes and check and drop their luggage at the Rental Car Center and Terminal 3 Curbside. The Rental Car Center allows customers to then proceed onto the shuttle bus without luggage. At Terminal 3 Curbside, customers can check in for flights and check their baggage curbside for multiple airlines...

NORWALK, Conn., March 19, 2024 (GLOBE NEWSWIRE) — Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, will host a conference call on Thursday, March 28, 2024 at 5:00 p.m. Eastern time to discuss its financial results for the three and twelve months ended December 31, 2023. The Company’s results will be reported in a press release prior to the call. Reed’s management will host the conference call, followed by a question-and-answer period. Date: Thursday, March 28, 2024Time: 5:00 p.m. Eastern timeToll-free dial-in number: (844) 850-0544International dial-in number: (412) 542-4115Conference ID: 10187056Webcast: Reed’s Q4 & FY 2023 Conference Call Please dial into the conference call 5-10 minutes prior to the start time. An operator will register...

Agricultural biotechnology company joins the ranks of Nvidia, YouTube, Taco Bell, and more SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that it has been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2024, ranking as the 2nd most innovative company in the agriculture category. This year’s list shines a spotlight on businesses that are shaping industry and culture through their innovations. These organizations are setting new standards and achieving remarkable milestones in all sectors of the economy. Alongside the World’s 50 Most Innovative Companies, Fast Company recognizes 606...

Enhanced reporting facilitates impactful client conversations and informed decision making regarding audiences across the marketing funnel LITTLE ROCK, Ark., March 19, 2024 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, powered by its proprietary IntentKey artificial intelligence (AI) that serves brands and agencies, has announced significant enhancements to its custom-designed, AI-powered Insights Dashboard, detailing target audience interests and campaign performance. Inuvo’s AI was designed to solve the two biggest problems facing advertisers in a cookieless world: audience targeting and performance measurement. With this update, clients now have the information they need to make better decisions. The enhanced dashboard includes three key sections: Funnel Overview: This added...

AI-powered Endpoint Detection and Response solution, backed by a $250,000 financial protection plan, significantly reduced the number and severity of cyber losses for enterprises Scottsdale, Ariz., March 19, 2024 (GLOBE NEWSWIRE) — CISO Global (NASDAQCM: CISO), an industry leader as a managed cybersecurity and compliance provider, successfully tested the effectiveness of its CHECKLIGHT® Endpoint Detection and Response (EDR) solution under strenuous and highly targeted environments over the past year. Through actuarial data collection, CISO Global found that it significantly reduced the number and severity of cyber losses to the very low single digits for users of the technology. Based on AI technology developed for the federal government, the solution provides North American businesses with an immediate, affordable, and unparalleled...

SEATTLE, March 19, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced that the pre-menopausal, Estrogen Receptor positive (ER+) / Human Epidermal Growth Factor Receptor 2 negative (HER2-), breast cancer patient who received neoadjuvant and adjuvant (Z)-endoxifen therapy under an FDA-approved “expanded access” program has completed five years of treatment. As of the date of this press release, the patient remains cancer-free and has reported no significant safety or tolerability issues over the course of her treatment. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer. “We believe this patient, and her successful treatment journey, is...